Pharmaceutical Care Network Europe

The Pharmaceutical Care Network Europe (PCNE) was established in 1994 by a number of European pharmaceutical care researchers. It became an official association (under Dutch law) in 2004.

Medication Review Drug-related problem classification Guidelines and Indicators

PCNE Medication review symposium 2011, Dublin, Ireland

Number two in 2011

18th October 2011


Introduction

This second Medication Review symposium was the fourth official meeting of the PCNE working group. 

Medication review (Drug Use Review, DUR) is a process that is part of the quality assurance of medication therapy (drug therapy). A retrospective review does not focus on drug-use alone, but on prescribing medicines and administration/actual use.  The aim of the review is identifying problems or potential problems, or medication errors, in view of the desired outcomes. There are several published methods coupled with criteria (implicit & explicit) but it is still unclear how a review should be conducted, and what methods are currently being studied in practice. The different criteria often need an adaptation to national customs and formularies. The focus of the working group is retrospective medication review.

Summary previous work of Working Group. Prof. Dr. Kurt Hersberger, Switzerland

Organising & scientific committee

Nina Griese, Germany
Kurt Hersberger, Switzerland
Foppe van Mil, the Netherlands

Lectures

    • Inappropriate prescribing: Mapping the characteristics of evaluation tools.Carole Kaufmann, Switzerland
    • The basics of the Stopp-Start criteria. Dr. Cristin Ryan, N. Ireland
    • The Spanish approach to cognitive services, Medication review with Follow Up. Dr. Miguel Angel Gastellurutia, Spain
    • Medication review developments in Ireland. Ms. Jean-Anne Morrissey, Ireland
    • Collaborative Medication Review Practices in Europe. Dr. Saija Leikola, Finland